See also this year's filing and all EDGAR filings for this company.
PDF Report 0000886163_2026_Ligand_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0000886163, Ligand Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 832,271,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 326,979,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 401,387,000 |
| 4 | LiabilitiesCurrent | 37,447,000 |
| 5 | LiabilitiesNoncurrent | 20,833,000 |
| 6 | remainder_Liabilities | 485,145,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 91,410,424 |
| 9 | ResearchAndDevelopmentExpense | 79,457,387 |
| 10 | remainder_Expenses | 101,859,897 |
| 11 | remainder_Revenues | 250,363,070 |
| 12 | remainder_NetIncome | 79,775,187 |
| 13 | remainder_ComprehensiveNetIncome | 7,742,179 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,560,637,000 |
| 1 | Liabilities | 543,425,000 |
| 2 | Expenses | 272,727,708 |
| 3 | Revenues | 250,363,070 |
| 4 | StockholdersEquity | 1,017,212,000 |
| 5 | NetIncome | 57,410,549 |
| 6 | ComprehensiveNetIncome | 61,281,638 |
| 7 | BaseVar | 1,357,335,072 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.17 |
| 9 | EconomicCapitalRatio | 3.14 |
Edgar->Model Mapping
Feature Distribution
Change over Time
